28 May 2025 in Future Science OA
Breast cancer (BC) remains the most common cancer among women worldwide. Early detection plays a vital role in reducing morbidity and mortality. This study aimed to assess Jordanian women's awareness of BC signs and symptoms to support timely recognition and intervention. A nationwide cross-sectional study was conducted involving 381 Jordanian women from the general community. Participants completed a self-administered questionnaire assessing their knowledge of BC signs and symptoms using a three-point Likert scale ("Yes," "Unsure," "No"). Demographic variables were analyzed for association with knowledge levels using Pearson's Chi-square or Fisher's Exact Test. 80.3% of participants demonstrated good awareness of BC signs and symptoms. Significant associations were found between knowledge levels and marital status (p = 0.000), age (p = 0.033), having children (p = 0.000), number of children (p = 0.003), education specialty (p = 0.000), and working area (p = 0.005). Most participants demonstrated a strong awareness of BC signs and symptoms. However, educational interventions are needed to target knowledge gaps, particularly among unmarried women.
26 February 2025 in Heliyon
1 January 2026 in Advances in Pharmacological and Pharmaceutical Sciences
Background: Hepatocellular carcinoma (HCC) is an aggressive and common liver cancer with high recurrence and late‐stage diagnosis. Despite multiple treatment options, their effectiveness is limited, especially in advanced stages. Hepatocellular cancer cells show elevated oxidative stress, which can be targeted therapeutically. Pharmacological ascorbate (P‐AscH − ) and methylseleninic acid (MSA) are redox‐active agents that are selectively cytotoxic to cancer cells by increasing reactive oxygen species (ROS) generation. However, the therapeutic potential of new redox‐active agents in HCC is still poorly investigated. Methods: HepG2 and THLE‐3 cells were treated with increasing concentrations of P‐AscH − (0–20 mM), MSA (0–40 µM), or a combination of both. Cell viability was assessed using the MTS assay. ROS levels, particularly hydroxyl radicals, were measured using the OH580 fluorescent probe. Catalase (CAT) activity and concentration were quantified via a colorimetric assay and ELISA, respectively. Results: P‐AscH − and MSA each induced dose‐dependent cytotoxicity in HepG2 cells without significantly affecting THLE‐3 normal liver cells. The combination treatment exhibited enhanced cytotoxicity in HepG2 cells, suggesting synergistic effects. ROS analysis revealed increased hydroxyl radical production in the combination group. Furthermore, CAT activity and expression were significantly altered in HepG2 cells treated with both agents, indicating impaired antioxidant defense and enhanced oxidative damage. Conclusion: The combination of P‐AscH − and MSA selectively enhances cytotoxicity in HCC cells by increasing oxidative stress and suppressing CAT activity. These findings support further exploration of this combinatory approach as a potential therapeutic strategy for HCC.
5 September 2026 in Future Science OA
1. Breast cancer remains a major health concern among Jordanian women and may occur at a younger age than in many Western populations [1–3]. Among benign breast lesions, fibroadenomas are common in...